NovaBay Pharmaceuticals (NBY) Earnings Date, Estimates & Call Transcripts

$0.08
0.00 (-2.65%)
(As of 05:25 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 28Estimated
Actual EPS
(Mar. 26)
-$0.95 Missed By -$0.95
Skip Charts & View Estimated and Actual Earnings Data

NBY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovaBay Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.41) EPS
Next Year EPS Consensus Estimate: $0.07 EPS

NBY Earnings Date and Information

NovaBay Pharmaceuticals last released its earnings data on March 26th, 2024. The reported ($0.95) EPS for the quarter. The company had revenue of $3.73 million for the quarter. NovaBay Pharmaceuticals has generated ($3.82) earnings per share over the last year (($3.82) diluted earnings per share). Earnings for NovaBay Pharmaceuticals are expected to grow in the coming year, from ($0.41) to $0.07 per share. NovaBay Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 28th, 2024 based off prior year's report dates.

NovaBay Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/28/2024
Estimated)
------- 
3/26/2024Q4 2023-($0.95)($0.95)($0.57)-$3.73 million    
11/9/2023Q3 2023-($0.37)($0.37)($0.37)-$3.27 million
8/10/2023Q2 2023-($1.27)($1.27)($1.27)-$4.61 million
5/11/2023Q1 2023-($0.85)($0.85)($0.85)-$3.12 million
3/30/2023Q4 2022-($4.33)($4.33)($4.33)-$3.64 million
11/14/2022Q3 2022-($3.50)($3.50)($3.50)-$3.83 million
8/11/2022Q2 2022-($1.40)($1.40)($1.40)-$3.05 million
3/29/2022Q4 2021-($0.70)($0.70)($0.70)-$2.64 million
11/11/2021Q3 2021-($1.75)($1.75)($1.75)-$1.84 million
8/12/2021Q2 2021-($1.40)($1.40)($1.40)-$2.13 million
5/6/2021Q1 2021-($1.40)($1.40)($1.40)-$1.81 million

NovaBay Pharmaceuticals Earnings - Frequently Asked Questions

When is NovaBay Pharmaceuticals's earnings date?

NovaBay Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 28th, 2024 based off last year's report dates. Learn more on NBY's earnings history.

How can I listen to NovaBay Pharmaceuticals's earnings conference call?

The conference call for NovaBay Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read NovaBay Pharmaceuticals's conference call transcript?

The conference call transcript for NovaBay Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded annual revenue of $14.73 million.

How much profit does NovaBay Pharmaceuticals generate each year?

NovaBay Pharmaceuticals (NYSE:NBY) has a recorded net income of -$9.64 million. NBY has generated -$3.82 earnings per share over the last four quarters.

What is NovaBay Pharmaceuticals's EPS forecast for next year?

NovaBay Pharmaceuticals's earnings are expected to grow from ($0.41) per share to $0.07 per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:NBY) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners